PortfoliosLab logoPortfoliosLab logo
ULBI vs. CBAT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ULBI vs. CBAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ultralife Corporation (ULBI) and CBAK Energy Technology, Inc. (CBAT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ULBI

1D
-3.25%
1M
-13.98%
6M
-9.58%
YTD
-1.05%
1Y
-34.34%
3Y*
4.25%
5Y*
-7.53%
10Y*
1.52%

CBAT

1D
-1.42%
1M
6M
YTD
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ULBI vs. CBAT - Yearly Performance Comparison


Correlation

The correlation between ULBI and CBAT is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jun 30, 2026

0.20

Fundamentals

Market Cap

ULBI:

$94.28M

CBAT:

$44.32M

EPS

ULBI:

-$0.49

CBAT:

-$0.10

PS Ratio

ULBI:

0.50

CBAT:

0.23

PB Ratio

ULBI:

0.73

CBAT:

0.00

Total Revenue (TTM)

ULBI:

$187.86M

CBAT:

$195.19M

Gross Profit (TTM)

ULBI:

$43.39M

CBAT:

$18.42M

EBITDA (TTM)

ULBI:

$6.73M

CBAT:

-$18.44M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ULBI vs. CBAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULBI
ULBI Risk / Return Rank: 1717
Overall Rank
ULBI Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
ULBI Sortino Ratio Rank: 1919
Sortino Ratio Rank
ULBI Omega Ratio Rank: 2020
Omega Ratio Rank
ULBI Calmar Ratio Rank: 1414
Calmar Ratio Rank
ULBI Martin Ratio Rank: 1717
Martin Ratio Rank

CBAT

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULBI vs. CBAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ultralife Corporation (ULBI) and CBAK Energy Technology, Inc. (CBAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ULBICBATDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

0.92

Calmar ratioReturn relative to maximum drawdown

-0.77

Martin ratioReturn relative to average drawdown

-1.18

ULBI vs. CBAT - Sharpe Ratio Comparison


Loading charts...

Drawdowns

ULBI vs. CBAT - Drawdown Comparison

The maximum ULBI drawdown since its inception was -92.90%, which is greater than CBAT's maximum drawdown of -17.42%. Use the drawdown chart below to compare losses from any high point for ULBI and CBAT.


Loading charts...

Drawdown Indicators


ULBICBATDifference

Max Drawdown

Largest peak-to-trough decline

-92.90%

-17.42%

-75.48%

Max Drawdown (1Y)

Largest decline over 1 year

-44.69%

Max Drawdown (3Y)

Largest decline over 3 years

-68.83%

Max Drawdown (5Y)

Largest decline over 5 years

-68.83%

Max Drawdown (10Y)

Largest decline over 10 years

-68.83%

Current Drawdown

Current decline from peak

-76.90%

-17.42%

-59.48%

Average Drawdown

Average peak-to-trough decline

-63.51%

-10.35%

-53.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.05%

Volatility

ULBI vs. CBAT - Volatility Comparison


Loading charts...

Volatility by Period


ULBICBATDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.34%

Volatility (6M)

Calculated over the trailing 6-month period

41.11%

Volatility (1Y)

Calculated over the trailing 1-year period

56.32%

71.91%

-15.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.05%

71.91%

-12.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

54.37%

71.91%

-17.54%

Dividends

ULBI vs. CBAT - Dividend Comparison

Neither ULBI nor CBAT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ULBI vs. CBAT - Financials Comparison

This section allows you to compare key financial metrics between Ultralife Corporation and CBAK Energy Technology, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
47.45M
58.80M
(ULBI) Total Revenue
(CBAT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ULBI and CBAT have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ULBI and CBAT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer